DVYSR — Devyser Diagnostics AB Share News
0.000.00%
- SEK1.42bn
- SEK1.39bn
- SEK250.50m
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue
Brief: Devyser Diagnostics Board Not Proposing Dividend For 2025
Sweden's Devyser Q4 sales rise 12.1% yr/yr
Brief: Devyser Buys Cybergene AB
Brief: Devyser Enters Strategic Supply Agreement With Illumina
Brief: Devyser Wins Norwegian Tender For Devyser CFTR At Oslo University Hospital
Brief: Devyser Wins Four-Year Tender In France
Brief: CMS Sets Price For Devyser's Prenataldetect RHD Test At $192
Brief: Devyser Q3 Sales SEK 56.4 Million
Brief: Devyser Diagnostics CEO Buys SEK 508,682 Worth Of Co's Shares
Brief: Devyser Q2 Sales SEK 67.4 Million
Brief: Devyser Q1 Sales SEK 54.8 Million
Brief: Devyser Secures Tender Worth SEK 61.8 Mln
Brief: Devyser Appoints Jan Wahlström As New CEO
Brief: Devyser Genomic Laboratories Gets Accreditation From College Of American Pathologists
Brief: Devyser Secures SEK 16.8 Mln Tender In Italy